All In MedTech

Device Trial Radar · NCT06085352

Evaluate the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens in Patients Undergoing PRK Procedure

An Investigator Initiated, Randomized, Single Center Clinical Study to Evaluate the Safety, Efficacy Using the TetraLens, a Tetracaine Releasing Therapeutic Bandage Contact Lens Undergoing a Photorefractive Keratotomy Procedure (PRK)

Last checked: Nov 19, 2026Latest source record: Sep 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Jun 26, 2023

Primary completion

Dec 31, 2023

Study completion Jan 25, 2024

Sponsor

Lead sponsor
Vance Thompson VisionAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 16, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Early phase 1
Allocation
Randomized
Model
Crossover
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to determine the safety, efficacy, and comfort of the investigational TetraLens bandage contact lens in patients who have undergone photorefractive keratectomy (PRK). The main question\[s\] it aims to answer are: * Understand benefit of managing pain following the surgical procedure * Understand the safety of the Tetralens Participants will be asked to wear theTetraLens BCL in one eye for 6 days post-operatively and: document the daily quantity of oral analgesics needed and report ocular pain and contact lens comfort. Researchers will compare the study lens in one eye to a control lens in the contralateral (other eye)

Conditions

  • Ocular Pain

Interventions

  • TetraLens bandage contact lensDrug

    Methafilcon-A contact lens eluding tetracaine ophthalmic solution

  • Control Acuvue Oasys Bandage contact LensDevice

    Standard of care bandage contact lens

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of TetraLens BCL in the management of pain following surgical proceduresTime frame: 6 days post-operative
  2. Safety of TetraLens BCLTime frame: 6 days post-operative

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Vance Thompson Vision

    Sioux Falls, South Dakota

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.